<?xml version="1.0"?>

<document>
	<title>Substance P plasma levels in pregnancy and in various clinical
   disorders.</title>

	<author>Cusack-D.</author>
	<author>Cannon-D.</author>
	<author>Skrabanek-P.</author>
	<author>Powell-D.</author>

	<source>Horm-Metab-Res. 1979 Jul. 11(7). P 448-51.</source>

	<abstract>Using radioimmunoassay, immunoreactive SP (iSP) has been measured in
   the plasma of 162 hospital patients with various disorders and in the
   plasma of 67 pregnant women. In pregnancy, iSP was undetectable in
   40% women as compared to 12% in other hospital patients. The mean iSP
   plasma level in pregnancy was 37.8 +/- 4.6 (SEM) as compared to 77.1
   +/- 4.9 (SEM) pg/ml in other hospital patients. The results support
   earlier observations based on bioassay, suggesting that the blood of
   pregnant women contains higher concentrations of a SP-inactivating
   factor. Of the hospital patients, elevated levels of iSP were found
   in patients with chronic leukaemia, in one patient with a basaloid
   carcinoma of the anus, and in one patient with toxic liver damage and
   pancreatic insufficiency. No correlation was found between thyroid
   function and iSP plasma levels. ISP plasma levels in various
   gastrointestinal disorders were similar to those found in normal
   subjects.</abstract>

	<majorsubject>PREGNANCY</majorsubject>
	<majorsubject>SUBSTANCE-P: bl</majorsubject>

	<minorsubject>CYSTIC-FIBROSIS: bl</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>INTESTINAL-DISEASES: bl</minorsubject>
	<minorsubject>NEOPLASMS: bl</minorsubject>
	<minorsubject>RADIOIMMUNOASSAY</minorsubject>
	<minorsubject>THYROID-DISEASES: bl</minorsubject>

	<reference>001   ALUMETS J             HISTOCHEMISTRY                  52   217 977</reference>
	<reference>002   CANNON D              BIOCHEM SOC TRANS                5  1776 977</reference>
	<reference>003   EHRENPREIS T          ACTA PHYSIOL SCAND              27   380 953</reference>
	<reference>004$  HARKINS J             BRAIN RES                      147   405 978</reference>
	<reference>005   KOCIC-METROVIC D      PROC SCI SOC BOSNIA HERZEGOVI    1   113 961</reference>
	<reference>006   NAKANO T              JAPAN J PHARMACOL               25   43P 975</reference>
	<reference>007   OCONNELL R            IR J MED SCI                   145   392 976</reference>
	<reference>008   PARTINGTON MW         ARCH DIS CHILD                  52   386 977</reference>
	<reference>009$  PEARSE AGE            HISTOCHEMISTRY                  41   373 975</reference>
	<reference>010   PERNOW B              PROC SCI SOC BOSNIA HERZEGOVI    1    57 961</reference>
	<reference>011   POLAK JM              IN: FUJITA T                         103 976</reference>
	<reference>013   SKRABANEK PD          IR J MED SCI                   145   399 976</reference>
	<reference>014   SKRABANEK PD          IR J MED SCI                   147    47 978</reference>
	<reference>015   SKRABANEK PD          SUBSTANCE P                              978</reference>
	<reference>016   STERN PI              PROC SCI SOC BOSNIA HERZEGOVI    1   139 961</reference>

	<citation>1   SKRABANEK P           EUR J OBSTE GYNECOL REPR BIOL   11   157 980</citation>
	<citation>2   KAIYA  H              PSYCHIATRY RES                   5    11 981</citation>
	<citation>3   POLLOCK M             NEUROLOGY                       32  1311 982</citation>
	<citation>4   VERMA PS              EUR J PHARMACOL                 86   275 982</citation>
	<citation>5   SKRABANEK P           OBSTET GYNECOL                  61   641 983</citation>
	<citation>6   SKRABANEK P           IR J MED SCI                   153    47 984</citation>
	<citation>7   ZHANG CL              ACTA ZOOL SINICA                31   106 985</citation>

</document>
